http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012157977-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate | 2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012157977-A |
| titleOfInvention | THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR PRE-DIABETES |
| abstract | 1. A method of treating a patient suffering from a metabolic disorder, comprising the step of administering to a patient in need of such treatment a therapeutically effective amount of a therapeutic agent that increases the activity ratio of dopamine / norepinephrine and / or serotonin neurons. A method of treating a patient suffering from a metabolic disorder, comprising the step of administering to a patient in need of such treatment a therapeutic agent that increases the activity ratio of dopamine / noradrenoline and / or serotonin neurons, which increases the ratio of the activity of dopaminergic neurons to the activity of noradrenergic neurons in the central nervous system or in the hypothalamus the central nervous system of the specified patient. 3. A method of treating a patient suffering from a metabolic disorder, comprising the steps of: administering to a patient suffering from a metabolic syndrome, type 2 diabetes, obesity, prediabetes, a pharmaceutical composition comprising (1) at least one compound that stimulates an increase in the activity of central dopaminergic neurons in said subject, and (2) at least one compound that stimulates a decrease in the activity level of central noradrenergic and / or serotonin neurons in said subject. The method of claim 1, 2 or 3, wherein the metabolic disorder is selected from the group consisting of metabolic syndrome, type 2 diabetes, obesity, prediabetes, key elements of any metabolic disorder, insulin resistance, hyperinsulinemia, cardiovascular disease, elevated noradren � |
| priorityDate | 2010-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.